Sponsored
Sun Pharma elevates Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairman
Posted
Sun Pharma's India business head, Kirti Ganorkar, will become the managing director on September 1, succeeding founder Dilip Shanghvi. Shanghvi will transition to executive chairman, while his son Aalok will oversee North America as COO. Richard Ascroft will take over as CEO of North America, replacing Abhay Gandhi, as Sun Pharma continues its strategic leadership evolution.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
'Every time questions were asked, Gill answered with his bat' – Former Indian wicketkeeper
Parthiv Patel lauded Shubman Gill's exceptional performance in the recent England series, where...
Tata Motors Q1 results: Net profit drops 62% to Rs 4,003 crore on lower volumes and JLR tariff hit; revenue slips to Rs 1.04 lakh crore
Tata Motors' Q1 FY26 net profit plummeted 62.2% to ₹4,003 crore, impacted by volume declines...
Indra Bahadur Baniya to seek vote of confidence on August 12
KATHMANDU: Indra Bahadur Baniya, appointed as the sixth Chief Minister of Bagmati Province on...
'Dhadak 2' OTT release: Here's when, where you can watch
Dhadak 2, starring Siddhant Chaturvedi and Triptii Dimri, released in theaters on August 1, 2025,...